Contributions of EpitalonEoin

Contributions by EpitalonEoin, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,477 edits includes activity predating the current log.

1. 09:17, 16 Jul 2026 (diff | hist) MOTS-c 4,670 ±0 add the note that lyophilised material is not sterile unless stated
2. 05:02, 13 Jul 2026 (diff | hist) HOMA-IR 4,511 ±0 add the standardisation programme the assay is traceable to
3. 07:02, 19 Jun 2026 (diff | hist) MOTS-c 4,670 ±0 m expand §Reported effects
4. 19:12, 20 Mar 2026 (diff | hist) Haemoglobin A1c 4,243 ±0 m convert the interval table to include both conventional and SI units
5. 09:56, 6 Feb 2026 (diff | hist) Trial data comparison 7,303 ±0 expand §How this page calculates so the formula is visible
6. 13:34, 31 Jan 2026 (diff | hist) Bacterial endotoxin test 5,317 ±0 correct the resolution formula — the denominator is the sum of the widths
7. 09:42, 2 Jan 2026 (diff | hist) Melanotan II 4,649 ±0 m the lead said "widely used"; replaced with what the sources actually support
8. 19:04, 21 Sep 2025 (diff | hist) Growth hormone secretagogue 4,613 +118 expand §Material in research supply
9. 08:32, 16 Jul 2025 (diff | hist) Repackaging 4,506 ±0 split §Cold chain from §Storage after receipt
10. 11:35, 5 Jun 2025 (diff | hist) MOTS-c 3,596 ±0 add see also to the closely related analogue
11. 15:14, 30 Mar 2025 (diff | hist) MOTS-c 3,248 +552 split the pharmacology section from the marketing history
12. 02:32, 29 Jan 2025 (diff | hist) Sangon Biotech 5,001 +192 rm the comparison with another supplier; there is no common basis for it
13. 10:36, 12 Dec 2024 (diff | hist) MOTS-c 2,051 ±0 move the vendor-availability paragraph out; that is not article material
14. 02:47, 10 Nov 2024 (diff | hist) Purity claim inflation 2,238 ±0 expand §What a purity figure does establish
15. 19:37, 27 Sep 2024 (diff | hist) TRIUMPH trial programme 1,956 +739 add the discontinuation rate for adverse events in both arms